Grant: Operating Grant - PA: Regional Partnership Program : Manitoba
University of Manitoba
$100,000.00
Preclinical Studies for Treatment of Hydrocephalus
EF 2009-10
Résumé
Hydrocephalus is a common brain disease in which fluid (cerebrospinal fluid or CSF) accumulates inside of the brain thereby causing dysfunction and damage. It may affect infants, children, and adults. The surgical treatment, known as shunting, involves placement of a drain tube in the brain to divert the CSF to another part of the body. However, complications including infection are common in infants and the elderly, therefore surgeons may not rush to shunt affected people. This research will identify safe drugs that can prevent brain damage until a time when a shunt can be safely placed.
Programme
Operating Grant - PA: Regional Partnership Program : Manitoba
Bénéficiaire
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
207350
Name
Del Bigio Marc R
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Manitoba Health Research Council
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Behavioural Sciences - A: Neurobiological Basis of Behavioural Processes
Projecttitle
Preclinical Studies for Treatment of Hydrocephalus
Programtype2
Operating Grants
Orgnameinp2
University of Manitoba
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: Regional Partnership Program : Manitoba
Keyworddelim
Animal Model; Behavior; Brain; Drug Therapy (Preclinical); Hydrocephalus; Imaging; Neurological Disorder; Neuropathology; Neuroprotection
Abstract
Hydrocephalus is a common brain disease in which fluid (cerebrospinal fluid or CSF) accumulates inside of the brain thereby causing dysfunction and damage. It may affect infants, children, and adults. The surgical treatment, known as shunting, involves placement of a drain tube in the brain to divert the CSF to another part of the body. However, complications including infection are common in infants and the elderly, therefore surgeons may not rush to shunt affected people. This research will identify safe drugs that can prevent brain damage until a time when a shunt can be safely placed.
Competitiondate
201003
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Del Bigio, Marc R
Approvedterm
2 ans 0 mois
Cihrcontribution2
SPIR~ $100,000~ $0~
